Ceptaris Therapeutics
VerifiedPharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides
Launch date
Employees
Ownership
Firm valuation
$250m (Dealroom.co estimates Jul 2013.)
Malvern Iowa (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - Not yet verified | |
| N/A | $750k | Series A | |
| N/A | $500k | Early VC Not yet verified | |
| $4.5m | Series B | ||
| $14.5m | Series C Not yet verified | ||
| N/A | $3.1m | Early VC Not yet verified | |
| N/A | N/A | Early VC Not yet verified | |
| N/A | $14.4m | Series D Not yet verified | |
| $15m | Debt | ||
| $10m | Series D | ||
| $250m Valuation: $250m | Acquisition | ||
| Total Funding | $15.3m | ||